Cutaneous small vessel vasculitis associated with palpable purpura after COVID 19 Vaccination: A case report and a literature review

Daniela Tirotta *, Francesco Girelli, Maurizio Tassinari, Vincenzo Mazzeo and Paolo Muratori

Medicina Interna, Ospedale Morgagni-Pierantoni, Forlì, AUSL Romagna, Italy. 
 
Case Study
GSC Advanced Research and Reviews, 2022, 12(03), 131–144.
Article DOI: 10.30574/gscarr.2022.12.3.0242
Publication history: 
Received on 10 August 2022; revised on 15 September 2022; accepted on 17 September 2022
 
Abstract: 
Coronavirus disease 19 (Covid-19) vaccination is mostly safe and effective: adverse events following Covid-19 vaccination are generally mild and well tolerated. Adverse reactions may include cutaneous reactions and, rarely, cutaneous small vessel vasculitis associated with palpable purpura. We present the case of a small-vessel vasculitis after Covid-19 vaccination that manifested with no organ involvement or systemic symptoms, associated with self-resolution, and a review of the cases described in literature. We have collected the epidemiological and clinical features of these cases.
 
Keywords: 
Small vessel vasculitis; Covid-19 vaccination; Adverse reaction; Cutaneous reaction.
 
Full text article in PDF: 
Share this